Rota-081
Research payments
$108,144
Through program year 2020, $108,144 in research payments was reported against Rota-081, across 21 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $4,150 | 1 |
| 2019 | Research | $103,994 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nicola Klein Oakland, CA Named on 3 payments
- Barbara Pahud Kansas City, MO Named on 2 payments
- Keith Pulvermacher Marshfield, WI Named on 2 payments
- Elizabeth Reyes Anaheim, CA Named on 1 payment
- Joshua Fuller Provo, UT Named on 1 payment
- Michael Leonardi Charleston, SC Named on 1 payment
- Peter Silas Ogden, UT Named on 1 payment
- Shelly Senders Mayfield Heights, OH Named on 1 payment
- Alvin Gabrielsen Layton, UT Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.